|
Tender for Procurement Of Anticancer Drugs For The Year 2026-27 , Anastrazole Tab Ip 1 Mg , Azathioprine Tab Ip 50 Mg , Bicalutamide Tab Ip 50 Mg , Bleomycin Inj Ip 15 Units , Carfilzomib Inj 30 Mg , Cetuximab Inj 100 Mg , Cyclophosphamide Tab Ip 50 Mg , Dacarbazine Inj Ip/Usp 200 Mg , Dactinomycin Inj 0.5 Mg/3 Ml , Daunorubicin Inj Ip 20 Mg , Dexamethasone Tab Ip 8 Mg , Dexamethasone Tab Ip 4 Mg , Doxorubicin (Pegylated Liposomal) Inj 20 Mg , Doxorubicin (Pegylated Liposomal) Inj 50 Mg , Enzalutamide Cap 80 Mg , Eribulin Inj 0.44 Mg/Ml , Fludarabine Phosphate Inj Ip/ Usp 50 Mg , Ibandronate Tab 50 Mg , Megestrol Acetate Tab Ip/Bp/Usp 40 Mg , Melphalan Tab Ip 5 Mg , Mercaptopurine Tab Ip 50 Mg , Mesna Inj 200 Mg , Methotrexate Inj (Intrathecal, Preservative Free) 15 Mg , Methotrexate Tab Ip 2.5 Mg , Mitomycin For Inj Ip/Usp 10 Mg , Mitoxantrone Infusion Bp/Usp 20 Mg , Pomalidomide Cap 2 Mg , Procarbazine Hcl Cap Ip 50 Mg , Protein Bound Paclitaxel Inj 100 Mg , Rasburicase Inj 1.5 Mg , Regorafenib Tab 40 Mg , Rucaparib Tab 300 Mg , Sorafenib Tosylate Tab Ip 200 Mg , Tamoxifen Tab Ip 20 Mg , Tegafur +Uracil Cap 100 Mg + 224 Mg , Thalidomide Cap Usp 100 Mg , Vinblastine Sulphate Inj Ip 10 Mg , Vincristine Sulphate Inj Ip/Usp 1 Mg , Zoledronic Acid Inj Ip 4 Mg , Cyclophosphamide Inj Ip 200 Mg , Cyclophosphamide Inj Ip 500 Mg , Cyclophosphamide Inj Ip 1 Gm , Decitabine Inj 50 Mg , Decitabine Inj 30 Mg , Everolimus Tab 10 Mg , Everolimus Tab 5 Mg , Flurouracil Inj Ip 250 Mg , Flurouracil Inj Ip 500 Mg , Leucovorin Calcium Inj Ip 50 Mg , Leucovorin Calcium Inj Ip 15 Mg , Octreotide Inj 30 Mg , Octreotide Inj 20 Mg
|
